Correlation Between Zymeworks Common and Emergent Biosolutions

Can any of the company-specific risk be diversified away by investing in both Zymeworks Common and Emergent Biosolutions at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zymeworks Common and Emergent Biosolutions into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Zymeworks Common Stock and Emergent Biosolutions, you can compare the effects of market volatilities on Zymeworks Common and Emergent Biosolutions and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zymeworks Common with a short position of Emergent Biosolutions. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zymeworks Common and Emergent Biosolutions.

Diversification Opportunities for Zymeworks Common and Emergent Biosolutions

0.61

Correlation Coefficient

Zymeworks Common  Emergent Biosolutions

Poor diversification

The 3 months correlation between Zymeworks and Emergent is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Zymeworks Common Stock and Emergent Biosolutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emergent Biosolutions and Zymeworks Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zymeworks Common Stock are associated (or correlated) with Emergent Biosolutions. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emergent Biosolutions has no effect on the direction of Zymeworks Common i.e., Zymeworks Common and Emergent Biosolutions go up and down completely randomly.

Pair Corralation between Zymeworks Common and Emergent Biosolutions

Given the investment horizon of 90 days Zymeworks Common Stock is expected to generate 0.76 times more return on investment than Emergent Biosolutions. However, Zymeworks Common Stock is 1.31 times less risky than Emergent Biosolutions. It trades about 0.19 of its potential returns per unit of risk. Emergent Biosolutions is currently generating about 0.08 per unit of risk. If you would invest  1,483  in Zymeworks Common Stock on August 26, 2025 and sell it today you would earn a total of  1,016  from holding Zymeworks Common Stock or generate 68.51% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Zymeworks Common Stock  vs.  Emergent Biosolutions

Zymeworks Common Stock

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Zymeworks Common Stock are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak primary indicators, Zymeworks Common exhibited solid returns over the last few months and may actually be approaching a breakup point.

Emergent Biosolutions

Risk-Adjusted Performance

Mild

Compared to the overall equity markets, risk-adjusted returns on investments in Emergent Biosolutions are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile fundamental drivers, Emergent Biosolutions unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Zymeworks Common and Emergent Biosolutions

The main advantage of trading using opposite Zymeworks Common and Emergent Biosolutions positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zymeworks Common position performs unexpectedly, Emergent Biosolutions can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emergent Biosolutions will offset losses from the drop in Emergent Biosolutions' long position.

The idea behind Zymeworks Common Stock and Emergent Biosolutions pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.